The Imperial College Medical Cannabis Research Group at Imperial College London specializes in developing novel therapies targeting the endocannabinoid system through comprehensive in vitro, in vivo, and clinical translational research. Backed by a leading UK institution, the group advances medical cannabis science with a focus on bridging laboratory findings to clinical applications.

‌